Marcella Tazzari

📣Excited to kick off XXI NIBIT MEETING today in beautiful Palermo☀️! Looking forward to connecting with immuno-oncology leaders, sharing insights, and exploring the latest discovery in cancer immunotherapy. #NIBIT2024 #Networking #Learning #science

@merlini_ale @fumagallielena_ @SarcomaUniTo Brava Ale

It has been a true honor to receive the research award “Daniele Rosa” for work done by our @SarcomaUniTo group! The award will support our translational research activity, we are very grateful 🙏 #associazionedarosaonlus #darosanascecosa 🌹 quotidianocanavese.it/cultura-eventi…

Pic of few days ago @ItaSarcomaGroup Annuale Meeting. A very inspiring discussion after the great Lecture by W.H. Fridman on Tumor Microenviroment and TLS in Sarcomas and Cancer. Thank you @SilviaStacchia for the opportunity to be there!

@alegronchi @merlini_ale @ItaSarcomaGroup It has been great! Thank you for the fruitful discussion

Prof W.H. Fridman presenting at the ⁦@ItaSarcomaGroup⁩ annual meeting about the role of tertiary lymphoid structure in predicting response to immune check point inhibitors in sarcoma. Chemo and rad may help incidesse the immune infiltrate and their presence in the tumor!

The Frontiers' Research Topic I am leading as Guest Editor together with Marcel Deckert and Johannes Textor has a new submission deadline: 14th October 2022 frontiersin.org/research-topic…

@Sarcoma_papers pubmed.ncbi.nlm.nih.gov/35412415/

#airc #irst #immunotherapy A great opportunity! Grateful

Le #celluletumorali più centrali proliferano di più e diventano più forti e aggressive. Conoscere questi aspetti potrebbe aiutare a comprendere meglio i meccanismi alla base delle #metastasi. Scopri di più⬇ #airc #ricerca bit.ly/3dOAVoq

Take Genetics, Epigenetics and Immunity, mix them together to better characterize and understand sarcomas and define new avenues to tackle these diseases. 👇🏻👩🏻‍🔬🔬📚 #healthcare #medicine #research #science #airc #irst #ior mdpi.com/1422-0067/22/1…

Paper accepted for publication; 744 days since data released on BioRxiv, 2 journals in review, 7 reviewers, 4 rounds of resubmission, thousands of words and numerous additional expts in response. #bereasonable #thinkofECRcareers, please

Check out our latest work @NatureComms! We developed a human #organotypic #melanoma culture and used it to address the plasticity of conventional type 2 #dendriticcells in the #tumourmicroenvironment 🔬 #immunooncology #organotypictumormodels #immuneescape #aircforabroad

The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture | Nature Communications ⁦@StefaniaDB8⁩ ⁦@TIL_Radboudumc⁩ ⁦@IRSTufficiale⁩ ⁦@AIRC_it⁩ nature.com/articles/s4146…

Very proud to share our latest work out today in @NatureComms! We developed a human #organotypic #melanoma culture, and showed that the #tumourmicroenvironment drives the conversion of immunostimulatory #dendriticcells into an immunosuppressive phenotype. nature.com/articles/s4146…

Reggio Emilia Aiom e Sifo dibattito sulla centralizzazione UFA e reti oncologiche. Irst-irccs c'è.

#Prevenzione e #ricerca salvano la vita. Oggi non perdere l'appuntamento in 3.600 piazze con l' #AzaleadellaRicerca per i tumori femminili.

Esperti di fama mondiale nella classe della Multidisciplinary #Osteoncology #School bit.ly/2f2YCsH #tumore

inaugurato il Centro Risorse #Biologiche @IRSTufficiale per la conservazione per #ricerca di tessuti #oncologia bit.ly/2fxOQzi

#Ricerca AIRC: Terapie molecolari e immunoterapia per uno dei più frequenti sarcomi della pelle bit.ly/2cts8Gn